AnalystsMichael FreemanMichael Freeman's Stock Forecasts
AnalystsMichael Freeman
Sectors:
Analyst Ranking
Top 46%
#2401 out of 5256 analysts
Average Return
+10.34%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
Michael Freeman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Disc Medicine IncIRON | +40.41% | $50.86 | $71.41 | 2025-06-10 - 2026-04-20 | Strong Buy |
Dyne Therapeutics IncDYN | +37.41% | $14.57 | $20.02 | 2025-06-10 - 2026-04-20 | Buy |
Tectonic Therapeutic IncTECX | +22.38% | $23.50 | $28.76 | 2025-06-10 - 2026-04-20 | Buy |
Wave Life Sciences LtdWVE | +5.42% | $7.19 | $7.58 | 2025-06-10 - 2026-04-20 | Buy |
Michael Freeman Analyst Color
Get additional color on Michael Freeman's coverage of popular stocks
Michael Freeman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | 1 | Buy | $14.00 | +84.70% | Assumes | 10 months ago |
Tectonic Therapeutic IncTECX | 1 | Buy | $76.00 | +164.26% | Reinstates | 10 months ago |
Dyne Therapeutics IncDYN | 1 | Buy | $37.00 | +84.82% | Assumes | 10 months ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | +24.63% | Reinstates | 10 months ago |
Avidity Biosciences IncRNAM | 1 | Strong Buy | $65.00 | +340.68% | Initiates Coverage On | 10 months ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.